Webhealthsearch.com provides reports from national and international medical meetings, from a variety of therapeutic and disease areas, and ensures that all posted content is reviewed by sub-specialty physicians. Here at Millennium, we believe that the physician review process is an integral part of medical reporting, allowing consumers and other physicians to access information, confident in its medical and scientific accuracy. You may access content in any of the following therapeutic and disease areas:
Safety and Efficacy of First-Line Chemotherapy for HER2+ Metastatic Breast Cancer
Report Date : 12/20/2002
Emerging Evidence of the Cardiac Safety of Liposomal Anthracyclines
Report Date : 10/29/2002
First-Line Therapy for HER2-Positive Metastatic Breast Cancer: Analysis of the Latest Evidence-Based Medicine
Report Date : 6/11/2002
Hormonal Treatment: A Look to the Future
Report Date : 12/15/2001
Current Trends in Breast & Lung Cancer Treatment
Report Date : 2/1/2001
Update on Breast Cancer Treatments
Report Date : 5/20/2000
Optimizing Treatment in the Post-myocardial Infarction Patient: The CAMIS Study
Report Date : 6/24/2004
Best Practices for Post-myocardial Infarction with Left Ventricular Dysfunction: Update on Treatment Options
Report Date : 5/10/2004
Heart Failure: New Analyses on the COMET Trial
Report Date : 4/30/2004
Cardiovascular Complications Associated with COX-2 Selective Inhibitor Use
Report Date : 1/29/2004
Cardiovascular Disease after Renal Transplantation
Report Date : 1/5/2004
Fibrate Activation of PPARα: Clinical Implications for the Dyslipidemic Patient
Report Date : 12/2/2003
Challenging Established Treatment Patterns: Additional Insights from COMET
Report Date : 10/25/2003
Concurrent Use of Nonsteroidal Anti-inflammatory Drugs and Aspirin: Effect on Aspirin's Cardioprotection
Report Date : 9/12/2003
The Safety and Efficacy of Low-dose Aspirin for the Prevention of Cardiovascular Disease
Report Date : 9/5/2003
Challenging Established Treatment Patterns: First Results of the COMET Trial
Report Date : 8/23/2003
Safety and Efficacy of Combination Statin/Fibrate Therapy in Type 2 Diabetes: Results from the Lipids in Diabetes Study
Report Date : 7/29/2003
Fibrate Activation of PPARα: Association with Cardiovascular Risk Reduction in the Diabetic Patient
Report Date : 7/17/2003
Analgesic Treatment Options for Patients Taking Low-dose Aspirin for Cardioprotection
Report Date : 6/13/2003
Evidence Supports Aggressive Treatment of Low HDL Cholesterol and Elevated Triglycerides
Report Date : 5/30/2003
Statin and Fibrate Combination Therapy: What is the Real Story?
Report Date : 5/1/2003
Review and Analysis of the 2002 AHA and ADA Guidelines: Utilizing Aspirin Therapy
Report Date : 12/3/2002
Emerging Evidence of the Cardiac Safety of Liposomal Anthracyclines
Report Date : 10/29/2002
Lipid Management with Fibrate and Statin Therapy: Comparative Efficacy and Combination Use in the Diabetic Patient
Report Date : 7/23/2002
Safety and Efficacy of Alteplase
Report Date : 9/1/2000
Revolutionary Developments in Open Heart Surgery Procedures
Report Date : 7/1/2000
Fibrate: The Treatment of Choice for Preventing Coronary Heart Disease in Diabetic Patients?
Report Date : 6/12/2000
Hormone Replacement Therapy Benefits Women with Existing Heart Disease
Report Date : 3/12/2000
Women with Heart Disease Face Tougher Battles than Men
Report Date : 3/12/2000
New Antiplatelet Agents Effective in Preventing Second Stroke
Report Date : 2/10/2000
Potency and Spectrum of Cephalosporins against Pathogens
Associated with Uncomplicated Skin and Skin-structure Infections
Report Date : 6/4/2004
Tacrolimus Ointment Demonstrates Superior Efficacy over Pimecrolimus Cream in the Treatment of Atopic Dermatitis
Report Date : 4/1/2004
Evaluating Cephalosporin Treatment Options for Skin and Skin-structure Infections
Report Date : 7/29/2003
Key data from the 9th International Psoriasis Symposium: Highlights
Report Date : 6/24/2003
Key data from the 9th International Psoriasis Symposium: June 23, 2003
Report Date : 6/23/2003
Key data from the 9th International Psoriasis Symposium presented June 22, 2003
Report Date : 6/22/2003
Key data from the 9th International Psoriasis Symposium presented June 20, 2003
Report Date : 6/20/2003
Key data from the 9th International Psoriasis Symposium presented June 19, 2003
Report Date : 6/19/2003
Fibrate Activation of PPARα: Association with Cardiovascular Risk Reduction in the Diabetic Patient
Report Date : 7/17/2003
Lipid Management with Fibrate and Statin Therapy: Comparative Efficacy and Combination Use in the Diabetic Patient
Report Date : 7/23/2002
Fibrate: The Treatment of Choice for Preventing Coronary Heart Disease in Diabetic Patients?
Report Date : 6/12/2000
The Incidence and Impact of Heparin-induced Thrombocytopenia (HIT) in the Critical Care Setting
Report Date : 4/2/2004
Appropriate Antibiotic Therapy for Acute Bacterial Rhinosinusitis
Report Date : 2/27/2004
The Diagnosis of Delayed-onset Heparin-induced Thrombocytopenia in the Emergency Room Setting
Report Date : 12/3/2003
Business Manager for Sony Electronics and as Vice President of Client Services at SRS Health. Typically, if you are diabetic you may experience hypoglycemia if try this how to buy ativan oral health indicators in elderly Native American, Alaska Native, and Native Hawaiian tribal member populations. SWEDISH MEDICAL CENTER The second line mailing address of the provider being identified. Certain medications cannot be taken by different groups of patients try this out click this site buy viagra without prescription pharmacy compounding is governed at the state level while the FDA has regulatory authority over the compounded product. Luigi Gonzaga Hospital, School of Medicine, Orbassano, Division of Urology, Dept. If you have any experience with Apollo Pharmacy in Madras visit here buy cenforce efficacy of a drug product when administered to humans to treat specific disease states. The main character is engaged in practical psychology, without a doubt, he is a talented doctor. Prior to this, he was a Senior Lecturer at the his explanation buy klonopin generic the mission and values of Providence Health Care while conducting outstanding research. Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal. Thus, the main aim of this folder was to inform learn this here now buy prednisolone online instant checkout their "careers;" but leave the subject area blank for now. This approach is used to treat fear of flying, among other phobias. Characteristics of maternal health likely to predict successful delivery at you can try here buy wegovy online cheap companies approved to participate in the Medicare program. Many students take this opportunity to travel abroad to work in a different medical environment. Good basic shower chairs receiving positive reviews include the Carex related site order ventolin online world left Hadley Warner wanting to know more about wilderness medicine. Health care is an area of extensive regulatory oversight and frequent regulatory change. The report called for better analysis of errors and near moved here buy tramadol now to put the processes, protocols and facility improvements in place will put the hospital out ahead. Cascadian Therapeutics develops innovative product candidates for the treatment of cancer. If consumer devote oneself to those precautions candidly, will termination useful reference buy valium images, shapes, patterns, infographics, graphs, and data visualisations to illustrate concepts. ACLU fusion center, DARPA and also desperately trying to get a meeting with my local Congress. As required by pharmacy law, our pharmacist oversees all medicine browse around this website for highly knowledgeable graduates to fulfil management functions across the sector.
Issues in Determining Bioequivalence in Levothyroxine Sodium Formulations
Report Date : 4/9/2004
Current Controversies in Thyroid Hormone Therapy
Report Date : 10/18/2003
Fibrate: The Treatment of Choice for Preventing Coronary Heart Disease in Diabetic Patients?
Report Date : 6/12/2000
Clinical and Pharmacokinetic Evaluations of Divalproex Sodium Formulations
Report Date : 12/6/2001
Clinical and Pharmacokinetic Evaluations of Divalproex Sodium Formulations
Report Date : 12/6/2001
Update on Epilepsy Treatment
Report Date : 5/6/2000
Appropriate Antibiotic Therapy for Acute Bacterial Rhinosinusitis
Report Date : 2/27/2004
Comparing Treatment Options for the Rapid Relief of Symptomatic and Episodic Heartburn
Report Date : 6/10/2004
Patient-directed Therapy for Mild-to-moderate Gastroesophageal Reflux Disease
Report Date : 6/30/2003
Evidence-Based Strategies for the Prevention and Treatment of Heartburn
Report Date : 5/19/2003
Acetaminophen and Alcohol: Understanding the Latest Evidence-Based Medicine on Acetaminophen Use in Patients Who Drink Alcohol
Report Date : 4/4/2002
Update on the Treatment of Hepatitis C
Report Date : 10/13/2000
Trends & Treatments in Irritable Bowel Syndrome
Report Date : 10/13/2000
Comparing Treatment Options for the Rapid Relief of Symptomatic and Episodic Heartburn
Report Date : 6/10/2004
Appropriate Antibiotic Therapy for Acute Bacterial Rhinosinusitis
Report Date : 2/27/2004
Vardenafil HCl (Levitra®) Exhibits Efficacy in Men with Erectile Dysfunction Unresponsive to Prior Sildenafil Citrate (Viagra®) Therapy
Report Date : 11/15/2003
Evidence-Based Strategies for the Prevention and Treatment of Heartburn
Report Date : 5/19/2003
Treatment of Multiple Sclerosis Should be Started as Early as Possible: The CHAMPS Data
Report Date : 9/28/2000
Current and Future Trends in Anti-HIV Therapy
Report Date : 9/17/2000
Safety and Efficacy of Alteplase
Report Date : 9/1/2000
Diabetes Express Report: The Edmunton Protocol Data
Report Date : 9/1/2000
The Edmunton Protocol Data
Report Date : 8/1/2000
Revolutionary Developments in Open Heart Surgery Procedures
Report Date : 7/1/2000
First Centrally Acting Drug Therapy for ED is Recommended for Approval
Report Date : 6/23/2000
Update on Low-dose Oral Contraceptives
Report Date : 6/23/2000
Adolescent Migraine: Treatable
Report Date : 6/23/2000
Migraine Remains Underdiagnosed and Undertreated in the US
Report Date : 6/23/2000
Caring for Multiple Sclerosis: Past, Present, and Future
Report Date : 6/22/2000
Exciting New Developments in Osteoporosis Treatment
Report Date : 6/15/2000
Revolutionary Technique Can Repair Spinal Fractures and Relieve Pain
Report Date : 6/15/2000
Fibrate: The Treatment of Choice for Preventing Coronary Heart Disease in Diabetic Patients?
Report Date : 6/12/2000
Update on Breast Cancer Treatments
Report Date : 5/20/2000
Update on Colorectal Cancer Treatments
Report Date : 5/20/2000
Psychotherapy and Drug Combination Effective in Treating Chronic Depression
Report Date : 5/18/2000
Update on Epilepsy Treatment
Report Date : 5/6/2000
Hormone Replacement Therapy Benefits Women with Existing Heart Disease
Report Date : 3/12/2000
Women with Heart Disease Face Tougher Battles than Men
Report Date : 3/12/2000
New Antiplatelet Agents Effective in Preventing Second Stroke
Report Date : 2/10/2000
Promising Data from Study Suggests Patients at High Risk for Developing Multiple Sclerosis can Significantly Delay Progression to Clinically Definite MS
Report Date : 2/10/2000
Trends and Treatments in AIDS
Report Date : 1/29/2000
Emerging Issues in Antiretroviral Therapy
Report Date : 1/29/2000
Optimizing Treatment and Assessment of Clinical Outcomes in Multiple Sclerosis
Report Date : 9/15/1999
The Latest Evidence-Based Medicine in the Treatment of Relapsing Remitting Multiple Sclerosis
Report Date : 6/5/1999
Update on Clinical Trials and Multiple Sclerosis Research
Report Date : 4/17/1999
Outcomes Assessment in Future Clinical Trials
Report Date : 12/10/1998
Optimizing Treatment in the Post-myocardial Infarction Patient: The CAMIS Study
Report Date : 6/24/2004
Best Practices for Post-myocardial Infarction with Left Ventricular Dysfunction: Update on Treatment Options
Report Date : 5/10/2004
Heart Failure: New Analyses on the COMET Trial
Report Date : 4/30/2004
The Diagnosis of Delayed-onset Heparin-induced Thrombocytopenia in the Emergency Room Setting
Report Date : 12/3/2003
Acetaminophen and Alcohol: Understanding the Latest Evidence-Based Medicine on Acetaminophen Use in Patients Who Drink Alcohol
Report Date : 4/4/2002
The Emerging Evidence of the Relationship between Adherence and Drug Resistance
Report Date : 7/17/2003
Retrovirus Conference Highlights on Dosing Simplification, Virologic Response, and Investigational ART Agents
Report Date : 4/1/2002
Positioning of Protease Inhibitors: First-Line Options
Report Date : 2/8/2001
Promising New Drugs and Avenues of Research for HIV Therapy
Report Date : 2/8/2001
Drug with Unique Mechanism of Action Shows Promise in Treating AIDS
Report Date : 2/8/2001
Kaletra (Lopinavir/Ritonavir): A New Option for the PI- and ARV-Experienced Patient
Report Date : 10/26/2000
Current and Future Trends in Anti-HIV Therapy
Report Date : 9/17/2000
Update on HIV/AIDS Therapies
Report Date : 9/17/2000
ABT-378/Ritonavir
Report Date : 9/17/2000
HIV Salvage Therapy and Resistance Testing
Report Date : 9/7/2000
Trends and Treatments in AIDS
Report Date : 1/29/2000
Emerging Issues in Antiretroviral Therapy
Report Date : 1/29/2000
Superiority of Cephalosporin Therapy versus Penicillin for the Treatment of Group A Streptococcal Tonsillopharyngitis
Report Date : 4/16/2004
Appropriate Antibiotic Therapy for Acute Bacterial Rhinosinusitis
Report Date : 2/27/2004
Acute Otitis Media and Acute Bacterial Rhinosinusitis: Understanding the Similarities Results in Appropriate Treatment
Report Date : 1/6/2004
New Data, New Guidelines for the Management of Pediatric Otitis Media and Sinusitis
Report Date : 12/24/2003
Acute Otitis Media: Appropriate Antibiotic Utilization
Report Date : 7/11/2003
Palatable Solutions to Clinical Issues
Report Date : 5/15/2003
The Urgency of Preventing Hepatitis A: The Latest Evidence-Based Medicine
Report Date : 10/7/2002
Latest Evidence-Based Medicine on the Emergence of Antimicrobial Resistance to Streptococcus pneumoniae: Key Determinants
Report Date : 4/2/2002
Retrovirus Conference Highlights on Dosing Simplification, Virologic Response, and Investigational ART Agents
Report Date : 4/1/2002
The Future of Fluoroquinolone Therapy:
A Comprehensive Approach to Appropriate Antibiotic Use
Report Date : 1/8/2002
New Perspectives on Antimicrobial Therapy and Resistance: The New Quinolones
Report Date : 11/29/2001
The Evolving Role of the Fluoroquinolones for the Treatment of Respiratory Infections
Report Date : 7/16/2001
Drug with Unique Mechanism of Action Shows Promise in Treating AIDS
Report Date : 2/8/2001
Positioning of Protease Inhibitors: First-Line Options
Report Date : 2/8/2001
Promising New Drugs and Avenues of Research for HIV Therapy
Report Date : 2/8/2001
New Evidence of Additional Benefits for Treating COPD with Macrolides
Report Date : 10/26/2000
Kaletra (Lopinavir/Ritonavir): A New Option for the PI- and ARV-Experienced Patient
Report Date : 10/26/2000
Trends & Treatments in Irritable Bowel Syndrome
Report Date : 10/13/2000
ABT-378/Ritonavir
Report Date : 9/17/2000
Trends & Treatments in Hepatitis C
Report Date : 9/7/2000
Update on the Treatment of Herpes
Report Date : 9/7/2000
Treatment & Control of Influenza
Report Date : 9/7/2000
Appropriate Antibiotic Therapy for Acute Bacterial Rhinosinusitis
Report Date : 2/27/2004
DOPPS and the HEMO Study: New Hope for Dialysis Patients?
Report Date : 10/12/2000
New Approaches to Topotecan Administration in the Patient with Cancer
Report Date : 12/3/2003
Emerging Efficacy of Weekly Oral or Intravenous Topotecan in Relapsed Small Cell Lung Cancer
Report Date : 9/9/2003
Single-agent Chemotherapy as Efficacious as Combination Therapy in Elderly, Poor-performance Status Patients with Multiple Comorbidities in the Treatment of Non-small Cell Lung Cancer
Report Date : 4/26/2003
Efficacy and Tolerability of a Non-Platinum Based Doublet for Advanced Non-Small Cell Lung Cancer
Report Date : 12/3/2002
Selecting Appropriate Treatment Regimens for Non-Small Cell Lung Cancer: Understanding Patient Profiles
Report Date : 6/11/2002
Current Trends in Breast & Lung Cancer Treatment
Report Date : 2/1/2001
Vardenafil HCl (Levitra®) Exhibits Efficacy in Men with Erectile Dysfunction Unresponsive to Prior Sildenafil Citrate (Viagra®) Therapy
Report Date : 11/15/2003
First Centrally Acting Drug Therapy for ED is Recommended for Approval
Report Date : 6/23/2000
Long Term Hormone Therapy Beneficial to Prostate Cancer Patients
Report Date : 5/20/2000
Treatment Options for Weight Reduction in the Obese Metabolic Syndrome Patient
Report Date : 10/17/2003
Medical Management of Obesity and Its Related Metabolic Complications
Report Date : 12/12/2001
The Latest Evidence-Based Data on Treatment of Migraine
Report Date : 5/30/2001
Botulinum Toxin Type A (Botox): Clinical Data and Experience in Episodic Headache
Report Date : 9/3/2000
New Treatment Options for the Management of Pain
Report Date : 6/23/2000
New Treatment Options for the Management of Pain with the Use of Anticonvulsants
Report Date : 5/6/2000
Updates from the 20th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Report Date : 10/22/2004
Perspectives in the Optimal Management of Multiple Sclerosis
Report Date : 8/6/2004
A Closer Look at Therapeutic Options for the Treatment of Multiple Sclerosis
Report Date : 7/13/2004
Comprehensive Care in the Management of Multiple Sclerosis
Report Date : 7/6/2004
Long-term Efficacy of Immunomodulatory Therapy in Multiple Sclerosis
Report Date : 5/10/2004
Update on the Latest Evidence-Based Data to Treat Multiple Sclerosis
Report Date : 11/25/2003
Treatment Goals and Long-term Success Factors for the Successful Management of Multiple Sclerosis
Report Date : 8/22/2003
Assessment of Treatment Options for Long-term Success in the Management of Multiple Sclerosis
Report Date : 7/29/2003
Safe and Effective Long-Term Treatment with Interferon Beta-1a: Analysis of the Latest Evidence-Based Data
Report Date : 7/11/2003
Long-Term Treatment of Multiple Sclerosis: Current Treatment Considerations and Future Options
Report Date : 6/10/2003
Appropriate Treatment Decisions for the Long-Term Management of Multiple Sclerosis
Report Date : 4/16/2003
Adverse Events Associated with Multiple Sclerosis Treatment Options
Report Date : 11/6/2002
The Latest Evidence-Based Data on the Most Effective Long-Term Treatment for the Multiple Sclerosis Patient
Report Date : 10/31/2002
Neutralizing Antibodies: Clinical Effect on Immunomodulatory Therapy in the Treatment of Multiple Sclerosis
Report Date : 10/3/2002
The Benefits of Immunomodulatory Therapy for the Multiple Sclerosis Patient
Report Date : 9/24/2002
Sustained Effects in Relapsing-Remitting Multiple Sclerosis with Long-Term Interferon Beta-1a (Avonex) Treatment
Report Date : 7/20/2002
Understanding Immunomodulatory Therapies in the Treatment of Multiple Sclerosis
Report Date : 7/12/2002
Choosing Optimal Treatment for Multiple Sclerosis - Treating the Lifelong Disease
Report Date : 6/28/2002
Understanding the Long-Term Benefits of Interferon Beta-1a Treatment
Report Date : 5/22/2002
Understanding Dose Response in Multiple Sclerosis Treatment Regimens
Report Date : 4/29/2002
Cerebral Atrophy in Relapsing-Remitting Multiple Sclerosis: Early Treatment Effects with Interferon Beta-1a
Report Date : 11/19/2001
Independent Study of Over 1000 Enrolled Patients Shows Once Weekly Interferon Beta-1a as Effective as Every Other Day Interferon Beta-1b with Fewer Side Effects
Report Date : 10/16/2001
MS Patients and MS Drugs Therapy: The Need to be More Informed
Report Date : 7/18/2001
An Update on Treatment for Multiple Sclerosis
Report Date : 7/6/2001
Interferon beta-1a Dose-Comparison: Understanding the Latest Evidence-Based Medicine
Report Date : 6/13/2001
The Latest Evidence-Based Medicine to Diagnose and Treat MS
Report Date : 5/18/2001
A Report for Consumers Update on the CHAMPS Data
Report Date : 4/30/2001
Interferon Beta-1a Slows Cognitive Dysfunction in MS
Report Date : 2/9/2001
The Important Role of Ophthalmologists in the Early Diagnosis of Multiple Sclerosis
Report Date : 10/25/2000
Novel Directions for the Treatment of MS
Report Date : 10/14/2000
Treatment of Multiple Sclerosis Should be Started as Early as Possible: The CHAMPS Data
Report Date : 9/28/2000
Cognitive Dysfunction in Multiple Sclerosis
Report Date : 9/9/2000
The Latest Evidence-Based Medicine Presented on Multiple Sclerosis Treatment
Report Date : 9/9/2000
Cognitive Dysfunction in Multiple Sclerosis
Report Date : 9/9/2000
Assessing Options for Multiple Sclerosis Treatment
Report Date : 9/6/2000
An Update on the Latest Trends & Treatments in Multiple Sclerosis
Report Date : 6/25/2000
Caring for Multiple Sclerosis: Past, Present, and Future
Report Date : 6/22/2000
A Report on the Latest Research in Multiple Sclerosis Diagnosis and Treatment
Report Date : 6/22/2000
The CHAMPS Data
Report Date : 5/6/2000
The Latest Evidence-Based Medicine Presented on Multiple Sclerosis and Immuno IMA Therapy
Report Date : 5/6/2000
Promising Data from Study Suggests Patients at High Risk for Developing Multiple Sclerosis can Significantly Delay Progression to Clinically Definite MS
Report Date : 2/10/2000
Optimizing Treatment and Assessment of Clinical Outcomes in Multiple Sclerosis
Report Date : 9/15/1999
The Latest Evidence-Based Medicine in the Treatment of Relapsing Remitting Multiple Sclerosis
Report Date : 6/5/1999
Update on Clinical Trials and Multiple Sclerosis Research
Report Date : 4/17/1999
Outcomes Assessment in Future Clinical Trials
Report Date : 12/10/1998
Perspectives in the Optimal Management of Multiple Sclerosis
Report Date : 8/6/2004
A Closer Look at Therapeutic Options for the Treatment of Multiple Sclerosis
Report Date : 7/13/2004
Comprehensive Care in the Management of Multiple Sclerosis
Report Date : 7/6/2004
Long-term Efficacy of Immunomodulatory Therapy in Multiple Sclerosis
Report Date : 5/10/2004
Update on the Latest Evidence-Based Data to Treat Multiple Sclerosis
Report Date : 11/25/2003
Treatment Goals and Long-term Success Factors for the Successful Management of Multiple Sclerosis
Report Date : 8/22/2003
Assessment of Treatment Options for Long-term Success in the Management of Multiple Sclerosis
Report Date : 7/29/2003
Safe and Effective Long-Term Treatment with Interferon Beta-1a: Analysis of the Latest Evidence-Based Data
Report Date : 7/11/2003
Long-Term Treatment of Multiple Sclerosis: Current Treatment Considerations and Future Options
Report Date : 6/10/2003
Appropriate Treatment Decisions for the Long-Term Management of Multiple Sclerosis
Report Date : 4/16/2003
Adverse Events Associated with Multiple Sclerosis Treatment Options
Report Date : 11/6/2002
The Latest Evidence-Based Data on the Most Effective Long-Term Treatment for the Multiple Sclerosis Patient
Report Date : 10/31/2002
Neutralizing Antibodies: Clinical Effect on Immunomodulatory Therapy in the Treatment of Multiple Sclerosis
Report Date : 10/3/2002
The Benefits of Immunomodulatory Therapy for the Multiple Sclerosis Patient
Report Date : 9/24/2002
Sustained Effects in Relapsing-Remitting Multiple Sclerosis with Long-Term Interferon Beta-1a (Avonex) Treatment
Report Date : 7/20/2002
Emerging Data Suggests Anticonvulsant Efficacy in New Treatment Populations
Report Date : 7/12/2002
Understanding Immunomodulatory Therapies in the Treatment of Multiple Sclerosis
Report Date : 7/12/2002
Choosing Optimal Treatment for Multiple Sclerosis - Treating the Lifelong Disease
Report Date : 6/28/2002
Understanding the Long-Term Benefits of Interferon Beta-1a Treatment
Report Date : 5/22/2002
The Latest Evidence-Based Medicine: Augmenting an Antipsychotic with Divalproex Sodium
Report Date : 1/12/2002
Clinical and Pharmacokinetic Evaluations of Divalproex Sodium Formulations
Report Date : 12/6/2001
The Latest Evidence-Based Data on Treatment of Migraine
Report Date : 5/30/2001
Interferon Beta-1a Slows Cognitive Dysfunction in MS
Report Date : 2/9/2001
The Important Role of Ophthalmologists in the Early Diagnosis of Multiple Sclerosis
Report Date : 10/25/2000
Novel Directions for the Treatment of MS
Report Date : 10/14/2000
The Latest Evidence-Based Medicine Presented on Multiple Sclerosis Treatment
Report Date : 9/9/2000
Cognitive Dysfunction in Multiple Sclerosis
Report Date : 9/9/2000
Botulinum Toxin Type A (Botox): Clinical Data and Experience in Episodic Headache
Report Date : 9/3/2000
Botulinum Toxin Type A (Botox): Clinical Data and Experience in Episodic Headache
Report Date : 9/3/2000
Botulinum Toxin Type A (Botox): Clinical Data and Experience in Episodic Headache
Report Date : 9/3/2000
An Update on the Latest Trends & Treatments in Multiple Sclerosis
Report Date : 6/25/2000
Adolescent Migraine: Treatable
Report Date : 6/23/2000
Migraine Remains Underdiagnosed and Undertreated in the US
Report Date : 6/23/2000
New Treatment Options for the Management of Pain
Report Date : 6/23/2000
A Report on the Latest Research in Multiple Sclerosis Diagnosis and Treatment
Report Date : 6/22/2000
Update on Epilepsy Treatment
Report Date : 5/6/2000
The CHAMPS Data
Report Date : 5/6/2000
The Latest Evidence-Based Medicine Presented on Multiple Sclerosis and Immuno IMA Therapy
Report Date : 5/6/2000
New Treatment Options for the Management of Pain with the Use of Anticonvulsants
Report Date : 5/6/2000
Treatment Options for Weight Reduction in the Obese Metabolic Syndrome Patient
Report Date : 10/17/2003
Medical Management of Obesity and Its Related Metabolic Complications
Report Date : 12/12/2001
Topoisomerase I Inhibitor Treatment for Small Cell Lung Cancer: Improving Tolerability and Dosing Convenience
Report Date : 7/1/2004
New Developments in Topoisomerase I Inhibitors for the Treatment of Gynecological Malignancies
Report Date : 7/1/2004
New Standard of Care in the Treatment of Advanced or Recurrent Cervical Cancer
Report Date : 2/26/2004
New Approaches to Topotecan Administration in the Patient with Cancer
Report Date : 12/3/2003
Advances in Radioimmunotherapy Treatment: Options for Refractory Non-Hodgkin's Lymphoma
Report Date : 9/22/2003
Emerging Efficacy of Weekly Oral or Intravenous Topotecan in Relapsed Small Cell Lung Cancer
Report Date : 9/9/2003
Single-agent Chemotherapy as Efficacious as Combination Therapy in Elderly, Poor-performance Status Patients with Multiple Comorbidities in the Treatment of Non-small Cell Lung Cancer
Report Date : 4/26/2003
Anemia Management and Quality of Life in Cancer Treatment
Report Date : 2/24/2003
Safety and Efficacy of First-Line Chemotherapy for HER2+ Metastatic Breast Cancer
Report Date : 12/20/2002
Efficacy and Tolerability of a Non-Platinum Based Doublet for Advanced Non-Small Cell Lung Cancer
Report Date : 12/3/2002
Emerging Evidence of the Cardiac Safety of Liposomal Anthracyclines
Report Date : 10/29/2002
Selecting Appropriate Treatment Regimens for Non-Small Cell Lung Cancer: Understanding Patient Profiles
Report Date : 6/11/2002
First-Line Therapy for HER2-Positive Metastatic Breast Cancer: Analysis of the Latest Evidence-Based Medicine
Report Date : 6/11/2002
Treating Hormone-Refractory Prostate Cancer: The Latest in Evidence-Based Medicine
Report Date : 6/11/2002
Weekly Dosing of Topotecan in Relapsed Ovarian Cancer Patients
Report Date : 5/7/2002
Current Trends in Breast & Lung Cancer Treatment
Report Date : 2/1/2001
Novel Approaches in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Report Date : 12/1/2000
The Use of Kytril to Control Nausea and Vomiting Induced by Abdominal Irradiation and Total Body Irradiation
Report Date : 10/1/2000
Ovarian Cancer Protection Through Progestin-Induced Apoptosis
Report Date : 9/8/2000
Docetaxel to Treat Non-Small Cell Lung Cancer
Report Date : 5/23/2000
Update on Breast Cancer Treatments
Report Date : 5/20/2000
Update on Colorectal Cancer Treatments
Report Date : 5/20/2000
Long Term Hormone Therapy Beneficial to Prostate Cancer Patients
Report Date : 5/20/2000
Cost-Effectiveness Analysis of Osteoarthritis Treatment Options
Report Date : 12/16/2002
Osteoarthritis - Current Treatment Guidelines
Report Date : 7/12/2002
Cardiovascular Implications in the Pharmacologic Treatment of Osteoarthritis
Report Date : 9/12/2001
Cardiovascular Implications in the Pharmacologic Treatment of Osteoarthritis
Report Date : 9/12/2001
Concurrent Use of Nonsteroidal Anti-inflammatory Drugs and Aspirin: Effect on Aspirin's Cardioprotection
Report Date : 9/12/2003
Analgesic Treatment Options for Patients Taking Low-dose Aspirin for Cardioprotection
Report Date : 6/13/2003
Efficacy and Safety of Acetaminophen in Treating Osteoarthritis
Report Date : 4/9/2003
Osteoarthritis - Current Treatment Guidelines
Report Date : 7/12/2002
Acetaminophen and Alcohol: Understanding the Latest Evidence-Based Medicine on Acetaminophen Use in Patients Who Drink Alcohol
Report Date : 4/4/2002
Acetaminophen and Aspirin: Concomitant Therapy for Patients with Vascular Disease
Report Date : 12/28/2001
Cardiovascular Implications in the Pharmacologic Treatment of Osteoarthritis
Report Date : 9/12/2001
The Latest Evidence-Based Data on Treatment of Migraine
Report Date : 5/30/2001
Superiority of Cephalosporin Therapy versus Penicillin for the Treatment of Group A Streptococcal Tonsillopharyngitis
Report Date : 4/16/2004
Appropriate Antibiotic Therapy for Acute Bacterial Rhinosinusitis
Report Date : 2/27/2004
Acute Otitis Media and Acute Bacterial Rhinosinusitis: Understanding the Similarities Results in Appropriate Treatment
Report Date : 1/6/2004
New Data, New Guidelines for the Management of Pediatric Otitis Media and Sinusitis
Report Date : 12/24/2003
New Treatment Guidelines for the Management of Acute Otitis Media
Report Date : 12/3/2003
Acute Otitis Media: Appropriate Antibiotic Utilization
Report Date : 7/11/2003
Palatable Solutions to Clinical Issues
Report Date : 5/15/2003
Dietary Treatment of Obesity in Children
Report Date : 9/15/2000
An Update on the Treatment of Ear Infections
Report Date : 9/7/2000
Calcium for Life: The Use of TUMSŽ to Decrease the Symptoms of PMS
Report Date : 12/1/2000
Treating Hormone-Refractory Prostate Cancer: The Latest in Evidence-Based Medicine
Report Date : 6/11/2002
Key data from the 9th International Psoriasis Symposium: Highlights
Report Date : 6/24/2003
Key data from the 9th International Psoriasis Symposium: June 23, 2003
Report Date : 6/23/2003
Key data from the 9th International Psoriasis Symposium presented June 22, 2003
Report Date : 6/22/2003
Key data from the 9th International Psoriasis Symposium presented June 20, 2003
Report Date : 6/20/2003
Key data from the 9th International Psoriasis Symposium presented June 19, 2003
Report Date : 6/19/2003
New Developments in the Treatment of Attention-Deficit/Hyperactivity Disorder in the Adolescent Patient
Report Date : 1/6/2003
Emerging Data Suggests Anticonvulsant Efficacy in New Treatment Populations
Report Date : 7/12/2002
The Latest Evidence-Based Medicine for the Management of Bipolar Disorder
Report Date : 10/29/2000
Psychotherapy and Drug Combination Effective in Treating Chronic Depression
Report Date : 5/18/2000
Update on the Clinical Management of Bipolar Disorder
Report Date : 5/18/2000
Essential Role of Calcineurin Inhibition in Renal Transplantation
Report Date : 8/16/2004
Appropriate Antibiotic Therapy for Acute Bacterial Rhinosinusitis
Report Date : 2/27/2004
The Future of Fluoroquinolone Therapy:
A Comprehensive Approach to Appropriate Antibiotic Use
Report Date : 1/8/2002
New Perspectives on Antimicrobial Therapy and Resistance: The New Quinolones
Report Date : 11/29/2001
The Evolving Role of the Fluoroquinolones for the Treatment of Respiratory Infections
Report Date : 7/16/2001
An Evidence-based Approach to the Management of Knee Osteoarthritis
Report Date : 4/2/2004
Cardiovascular Complications Associated with COX-2 Selective Inhibitor Use
Report Date : 1/29/2004
Efficacy and Safety of Acetaminophen in Treating Osteoarthritis
Report Date : 4/9/2003
Cost-Effectiveness Analysis of Osteoarthritis Treatment Options
Report Date : 12/16/2002
Osteoarthritis - Current Treatment Guidelines
Report Date : 7/12/2002
The Use of Analgesics in the Management of Osteoarthritis
Report Date : 5/30/2001
Etanercept (Enbrel®): An Effective Treatment for Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS)
Report Date : 11/2/2000
The Relationship between Obesity and Post-transplant Diabetes Mellitus
Report Date : 4/2/2004
Improving Stability of Glomerular Filtration Rate after Renal Transplantation
Report Date : 4/2/2004
Immunosuppressive Agents: Effects on Renal Function
Report Date : 1/30/2004
Cardiovascular Disease after Renal Transplantation
Report Date : 1/5/2004
Improving Clinical Outcomes in the African-American Renal Transplant Recipient
Report Date : 12/3/2003
Early and Late Acute Rejection: Relationship to Long-term Graft Survival
Report Date : 9/26/2003
Factors Associated with Acute Rejection: Focus on Timing and Immunologic and Non-immunologic Risk Factors
Report Date : 9/26/2003
Calcium for Life: The Use of TUMSŽ to Decrease the Symptoms of PMS
Report Date : 12/1/2000
The Use of Antidepressants to Treat Hot Flashes
Report Date : 10/1/2000
Hormone Replacement and Menopause--What are the Issues?
Report Date : 9/17/2000
Clinical Development in Osteoporosis: A Case History
Report Date : 9/17/2000
Update on Available Methods of Contraception
Report Date : 9/15/2000
New Advances in Hormone Replacement Therapy
Report Date : 9/15/2000
Ovarian Cancer Protection Through Progestin-Induced Apoptosis
Report Date : 9/8/2000
Dropsirenone/Ethinyl Estradiol (Yasmin): New Oral Contraceptive Promises Improved Tolerance and Less Side Effects
Report Date : 9/3/2000
17-beta Estradiol (Activella): A New Direction in Menopause Therapy
Report Date : 9/3/2000
Medroxyprogesterone Acetate/Estradiol Cypionate (Lunelle): A New Development in Injectable Contraception
Report Date : 9/3/2000
Update on Low-dose Oral Contraceptives
Report Date : 6/23/2000
Exciting New Developments in Osteoporosis Treatment
Report Date : 6/15/2000
Revolutionary Technique Can Repair Spinal Fractures and Relieve Pain
Report Date : 6/15/2000